Alexion Pharmaceuticals, Inc.

We are thrilled to announce the expansion of our AstraZeneca and Alexion Pharmaceuticals, Inc. hub in Mississauga Ontario where we will bring 700+ new scientific and highly-skilled life sciences jobs to the Greater Toronto Area. This expansion reinforces our commitment to advancing life sciences in Canada, with a focus on delivering life changing new medicines in oncology, rare diseases, and respiratory conditions. With the support of the Ontario Government | Gouvernement de l’Ontario and Invest Ontario we are fostering innovation that will drive economic growth and improve healthcare for patients in Canada and around the world. Since 2023 we have announced the creation of more than 1,200 new life sciences jobs in Canada, with a total investment exceeding C$1.3 B. This investment builds on our mission to transform the future of healthcare by unlocking the power of what science can do, for people, society and planet. Read more about our exciting journey here: https://spr.ly/6049xBPJd Premier Doug Ford Sylvia Jones Victor Fedeli Nina Tangri Aradhana Sarin Gaby Bourbara Gena Restivo Karen Heim Christina Archer Krista Olsen John Valliant

Congratulations to the student winners & participants of this year’s 2025 Harvard Rare Disease Hackathon, sponsored by National Organization for Rare Disorders! Their collective works focused on addressing critical stages of the #raredisease patient journey, including genomic diagnostics, symptom management and therapeutic targets.??And a special shout out to our Alexion guest judge Jin Wang and mentors, Barrett Duan and Chathuri Daluwatte, PhD! #HACKRARE? Harvard John A. Paulson School of Engineering and Applied Sciences

Neuromyelitis optica spectrum disorder (#NMOSD) is a rare and debilitating autoimmune disease characterised by unpredictable relapses, or attacks. Learn more about the condition below. #NMOAwarenessMonth

#NMOSD is associated with unpredictable attacks, also known as relapses, which can lead to long-term disability like vision loss or paralysis. Explore what other symptoms are associated with this #RareDisease below.

March is #NMOAwarenessMonth, an important time to support education and recognise the neuromyelitis optica spectrum disorder (#NMOSD) community. This year, we are proud to elevate the voices of those living with the disease and educate around NMOSD throughout the month.

We proudly stand with the rare disease community, highlighting their resilience and inspiring our continued efforts to tackle the long diagnosis timeline and life-changing treatments. #RareDiseaseDay

The crucial role of diagnosis and treatment availability for rare diseases can't be overstated. Discover the profound challenges faced by people living with rare diseases (PLWRDs) due to treatment unavailability and misdiagnoses, as detailed in the latest report from @Charles River Associates: https://spr.ly/6047IFhaF Join us in our commitment to alleviate the burden and improve the lives of those affected. #RareDisease

Millions of people live with a #RareDisease, yet less than 10% of the 10,000+ rare diseases have approved treatment options. Advancing the development of and providing greater access to innovative therapies are critical to fulfilling this unmet need.

Rare diseases not only impact health but also place a heavy economic burden on patients and society. The reduction in quality of life, combined with increased societal costs, underscores the need for urgent policy reforms and enhanced support systems. Read the latest report from @Charles River Associates and join us in supporting initiatives that prioritize the needs of people living with rare diseases: https://lnkd.in/eeHZhq4e??

Rare diseases create a staggering economic burden of €249.3 billion each year in Europe. This includes not only direct medical costs but also substantial direct non-medical and indirect costs, affecting individuals, families, and healthcare systems. Learn more in the latest report from @Charles River Associates:?https://lnkd.in/eeHZhq4e